Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocugen (OCGN) Other Accumulated Expenses (2015 - 2020)

Ocugen posted quarterly Other Accumulated Expenses of $9755.0 for Q4 2020, down 95.26% year-on-year from $205991.0 in Q1 2020, and down 95.1% on a QoQ basis from $199261.0 in Q3 2020.

Ocugen (OCGN) has 6 years of Other Accumulated Expenses data on file, last reported at $9755.0 in Q4 2020.

  • For the quarter ending Q4 2020, Other Accumulated Expenses fell 95.26% year-over-year to $9755.0; the trailing twelve-month figure through Dec 2020 stood at $9755.0 (down 95.26% YoY), and the FY2020 full-year result was $9755.0, down 95.26% from the prior year.
  • Other Accumulated Expenses for Q4 2020 stood at $9755.0, down from $199261.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $632000.0 in Q4 2017 and bottomed at $9755.0 in Q4 2020.
  • The 5-year median for Other Accumulated Expenses is $205425.5 (2019), against an average of $271315.5.
  • The widest annual swing landed in 2017, when Other Accumulated Expenses grew 24.41%; it then tumbled 95.26% in 2020.
  • A 5-year view of Other Accumulated Expenses shows it stood at $508000.0 in 2016, then advanced by 24.41% to $632000.0 in 2017, then slumped by 67.68% to $204242.0 in 2018, then rose by 0.86% to $205991.0 in 2019, then sank by 95.26% to $9755.0 in 2020.
  • The last three Other Accumulated Expenses figures came in at $9755.0 (Q4 2020), $199261.0 (Q3 2020), and $204860.0 (Q2 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Ocugen 452.01 Mn 452.01 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2020 9,755.00
Sep 30, 2020 199,261.00
Jun 30, 2020 204,860.00
Mar 31, 2020 206,415.00
Dec 31, 2019 205,991.00
Dec 31, 2018 204,242.00
Dec 31, 2017 632,000.00
Dec 31, 2016 508,000.00
Dec 31, 2015 548,000.00